Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report

Emily Henkle, Timothy Aksamit, Alan Barker, Charles L. Daley, David Griffith, Philip Leitman, Amy Leitman, Elisha Malanga, Theodore K. Marras, Kenneth N. Olivier, D. Rebecca Prevots, Delia Prieto, Alexandra L. Quittner, William Skach, John W. Walsh, Kevin Winthrop

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Nontuberculous mycobacteria (NTM) cause an increasingly important chronic and debilitating lung disease in older adults. Diagnosis is often delayed, although awareness among clinicians and patients is increasing.When necessary, treatment often lasts 18-24 months and consists of three or four antibiotics that can have serious side effects. Relapses are common and commonly require resumption of prolonged therapy. Given the need for improved diagnostic techniques and clinical trials to identify new therapies or to improve existing therapies, a group of North American clinicians and researchers formed the NTM Research Consortium (NTMRC) in 2014.TheNTMRCrecognized the importance of including the patient voice in determining research priorities for NTM. In November 2015, patients, caregivers, patient advocates, clinical experts, and researchers gathered for a 1-day meeting in Portland, Oregon funded by the Patient-Centered Outcomes Research Institute. The meeting goal was to define patient-centered research priorities forNTMlung infections. Patients expressed frustration with the number of people who have endured years of missed diagnoses or inadequate treatment of NTM. Participants identified as topresearch priorities the prevention ofNTM infection; approval of more effective treatments with fewer side effects and easier administration; understanding the best chest physiotherapy methods; validating and using tools to measure quality of life; and developing a disease-specific activity and severity assessment tool. Workshop participants agreed that two complementary objectives are critical to ensure the best achievable outcomes for patients: (1) additional clinician education to improve screening and diagnosis of NTMinfections; and (2) development of a geographically distributed network of experts in NTM disease to offer consultation or direct therapy after a diagnosis is made.

Original languageEnglish (US)
Pages (from-to)S379-S384
JournalAnnals of the American Thoracic Society
Volume13
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Nontuberculous Mycobacterium Infections
Nontuberculous Mycobacteria
Education
Lung
Research
Therapeutics
Patient Outcome Assessment
Research Personnel
Frustration
Group Psychotherapy
Infection
Caregivers
Lung Diseases
Thorax
Referral and Consultation
Quality of Life
Clinical Trials
Anti-Bacterial Agents
Recurrence

Keywords

  • Nontuberculous mycobacteria
  • Pulmonary disease
  • Quality of life

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine

Cite this

Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report. / Henkle, Emily; Aksamit, Timothy; Barker, Alan; Daley, Charles L.; Griffith, David; Leitman, Philip; Leitman, Amy; Malanga, Elisha; Marras, Theodore K.; Olivier, Kenneth N.; Prevots, D. Rebecca; Prieto, Delia; Quittner, Alexandra L.; Skach, William; Walsh, John W.; Winthrop, Kevin.

In: Annals of the American Thoracic Society, Vol. 13, No. 9, 01.09.2016, p. S379-S384.

Research output: Contribution to journalArticle

Henkle, E, Aksamit, T, Barker, A, Daley, CL, Griffith, D, Leitman, P, Leitman, A, Malanga, E, Marras, TK, Olivier, KN, Prevots, DR, Prieto, D, Quittner, AL, Skach, W, Walsh, JW & Winthrop, K 2016, 'Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report', Annals of the American Thoracic Society, vol. 13, no. 9, pp. S379-S384. https://doi.org/10.1513/AnnalsATS.201605-387WS
Henkle, Emily ; Aksamit, Timothy ; Barker, Alan ; Daley, Charles L. ; Griffith, David ; Leitman, Philip ; Leitman, Amy ; Malanga, Elisha ; Marras, Theodore K. ; Olivier, Kenneth N. ; Prevots, D. Rebecca ; Prieto, Delia ; Quittner, Alexandra L. ; Skach, William ; Walsh, John W. ; Winthrop, Kevin. / Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report. In: Annals of the American Thoracic Society. 2016 ; Vol. 13, No. 9. pp. S379-S384.
@article{338d0c165c8a493e8a871befb9e6aeaa,
title = "Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report",
abstract = "Nontuberculous mycobacteria (NTM) cause an increasingly important chronic and debilitating lung disease in older adults. Diagnosis is often delayed, although awareness among clinicians and patients is increasing.When necessary, treatment often lasts 18-24 months and consists of three or four antibiotics that can have serious side effects. Relapses are common and commonly require resumption of prolonged therapy. Given the need for improved diagnostic techniques and clinical trials to identify new therapies or to improve existing therapies, a group of North American clinicians and researchers formed the NTM Research Consortium (NTMRC) in 2014.TheNTMRCrecognized the importance of including the patient voice in determining research priorities for NTM. In November 2015, patients, caregivers, patient advocates, clinical experts, and researchers gathered for a 1-day meeting in Portland, Oregon funded by the Patient-Centered Outcomes Research Institute. The meeting goal was to define patient-centered research priorities forNTMlung infections. Patients expressed frustration with the number of people who have endured years of missed diagnoses or inadequate treatment of NTM. Participants identified as topresearch priorities the prevention ofNTM infection; approval of more effective treatments with fewer side effects and easier administration; understanding the best chest physiotherapy methods; validating and using tools to measure quality of life; and developing a disease-specific activity and severity assessment tool. Workshop participants agreed that two complementary objectives are critical to ensure the best achievable outcomes for patients: (1) additional clinician education to improve screening and diagnosis of NTMinfections; and (2) development of a geographically distributed network of experts in NTM disease to offer consultation or direct therapy after a diagnosis is made.",
keywords = "Nontuberculous mycobacteria, Pulmonary disease, Quality of life",
author = "Emily Henkle and Timothy Aksamit and Alan Barker and Daley, {Charles L.} and David Griffith and Philip Leitman and Amy Leitman and Elisha Malanga and Marras, {Theodore K.} and Olivier, {Kenneth N.} and Prevots, {D. Rebecca} and Delia Prieto and Quittner, {Alexandra L.} and William Skach and Walsh, {John W.} and Kevin Winthrop",
year = "2016",
month = "9",
day = "1",
doi = "10.1513/AnnalsATS.201605-387WS",
language = "English (US)",
volume = "13",
pages = "S379--S384",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "9",

}

TY - JOUR

T1 - Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection an NTM research consortium workshop report

AU - Henkle, Emily

AU - Aksamit, Timothy

AU - Barker, Alan

AU - Daley, Charles L.

AU - Griffith, David

AU - Leitman, Philip

AU - Leitman, Amy

AU - Malanga, Elisha

AU - Marras, Theodore K.

AU - Olivier, Kenneth N.

AU - Prevots, D. Rebecca

AU - Prieto, Delia

AU - Quittner, Alexandra L.

AU - Skach, William

AU - Walsh, John W.

AU - Winthrop, Kevin

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Nontuberculous mycobacteria (NTM) cause an increasingly important chronic and debilitating lung disease in older adults. Diagnosis is often delayed, although awareness among clinicians and patients is increasing.When necessary, treatment often lasts 18-24 months and consists of three or four antibiotics that can have serious side effects. Relapses are common and commonly require resumption of prolonged therapy. Given the need for improved diagnostic techniques and clinical trials to identify new therapies or to improve existing therapies, a group of North American clinicians and researchers formed the NTM Research Consortium (NTMRC) in 2014.TheNTMRCrecognized the importance of including the patient voice in determining research priorities for NTM. In November 2015, patients, caregivers, patient advocates, clinical experts, and researchers gathered for a 1-day meeting in Portland, Oregon funded by the Patient-Centered Outcomes Research Institute. The meeting goal was to define patient-centered research priorities forNTMlung infections. Patients expressed frustration with the number of people who have endured years of missed diagnoses or inadequate treatment of NTM. Participants identified as topresearch priorities the prevention ofNTM infection; approval of more effective treatments with fewer side effects and easier administration; understanding the best chest physiotherapy methods; validating and using tools to measure quality of life; and developing a disease-specific activity and severity assessment tool. Workshop participants agreed that two complementary objectives are critical to ensure the best achievable outcomes for patients: (1) additional clinician education to improve screening and diagnosis of NTMinfections; and (2) development of a geographically distributed network of experts in NTM disease to offer consultation or direct therapy after a diagnosis is made.

AB - Nontuberculous mycobacteria (NTM) cause an increasingly important chronic and debilitating lung disease in older adults. Diagnosis is often delayed, although awareness among clinicians and patients is increasing.When necessary, treatment often lasts 18-24 months and consists of three or four antibiotics that can have serious side effects. Relapses are common and commonly require resumption of prolonged therapy. Given the need for improved diagnostic techniques and clinical trials to identify new therapies or to improve existing therapies, a group of North American clinicians and researchers formed the NTM Research Consortium (NTMRC) in 2014.TheNTMRCrecognized the importance of including the patient voice in determining research priorities for NTM. In November 2015, patients, caregivers, patient advocates, clinical experts, and researchers gathered for a 1-day meeting in Portland, Oregon funded by the Patient-Centered Outcomes Research Institute. The meeting goal was to define patient-centered research priorities forNTMlung infections. Patients expressed frustration with the number of people who have endured years of missed diagnoses or inadequate treatment of NTM. Participants identified as topresearch priorities the prevention ofNTM infection; approval of more effective treatments with fewer side effects and easier administration; understanding the best chest physiotherapy methods; validating and using tools to measure quality of life; and developing a disease-specific activity and severity assessment tool. Workshop participants agreed that two complementary objectives are critical to ensure the best achievable outcomes for patients: (1) additional clinician education to improve screening and diagnosis of NTMinfections; and (2) development of a geographically distributed network of experts in NTM disease to offer consultation or direct therapy after a diagnosis is made.

KW - Nontuberculous mycobacteria

KW - Pulmonary disease

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84989329169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989329169&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201605-387WS

DO - 10.1513/AnnalsATS.201605-387WS

M3 - Article

C2 - 27627485

AN - SCOPUS:84989329169

VL - 13

SP - S379-S384

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 9

ER -